Month: June 2020

PHILADELPHIA and OXFORDSHIRE, United Kingdom, June 01, 2020 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (“Adaptimmune”)(Nasdaq: ADAP), a leader in cell therapy to treat cancer, today announced the pricing of an underwritten public offering of 20,500,000 of its American Depositary Shares (“ADSs”) at a price to the public of $11.00 per ADS. In connection with the offering, Adaptimmune has granted the underwriters a 30-day option to purchase up to an additional 3,075,000 ADSs at the public offering price. The gross offering size for this offering is expected to be $225.5 million, excluding any exercise of the underwriters’ option to purchase additional ADSs. All ADSs in this offering are being sold by Adaptimmune with net proceeds to be used to advance the development of Adaptimmune’s immunotherapies into and through clinical trials...

MONTREAL, June 01, 2020 (GLOBE NEWSWIRE) — WSP Global Inc. (TSX:WSP) (“WSP” or the “Corporation”) is pleased to announce that it has entered into an agreement with CIBC Capital Markets, National Bank Financial Inc. and TD Securities Inc. acting as joint bookrunners, on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Corporation will issue from treasury, and the Underwriters shall purchase on a “bought deal” basis, 5,080,000 common shares (the “Shares”) at a price of $86.00 per Share (the “Offer Price”) for gross proceeds to the Corporation of approximately $437 million (the “Offering”).In addition, WSP has entered into agreements under which the Corporation will complete a private placement of common shares at the Offer Price with Caisse de dépôt et placement du Québec (“CDPQ”), for...

MONTRÉAL, 01 juin 2020 (GLOBE NEWSWIRE) — Groupe WSP Global Inc. (TSX :WSP) (« WSP » ou la « Société ») est heureuse d’annoncer la conclusion d’une entente avec Marchés des capitaux CIBC, Financière Banque Nationale inc. et Valeurs Mobilières TD Inc., en qualité de coteneurs de livres, pour le compte d’un syndicat de preneurs fermes (collectivement, les « preneurs fermes »), aux termes de laquelle la Société émettra et les preneurs fermes s’engagent à souscrire 5 080 000 nouvelles actions ordinaires (les « actions ») au prix de 86.00 $ l’action (le « prix d’offre »), ce qui rapportera à la Société un produit brut d’environ 437 millions de dollars (le « placement »).De plus, WSP a conclu des conventions aux termes desquelles la Société réalisera un placement privé d’actions ordinaires au prix d’offre avec la Caisse de dépôt et placement...

LEXINGTON, Mass., June 01, 2020 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced the pricing of an underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $7.50 per share. In addition, Kaleido has granted the underwriters a 30-day option to purchase up to an additional 712,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds to Kaleido from this offering are expected to be approximately $35.6 million, before deducting underwriting discounts and commissions and other estimated offering expenses and excluding any exercise of the underwriters’ option to...

SAN DIEGO, June 01, 2020 (GLOBE NEWSWIRE) — Retail Opportunity Investments Corp. (NASDAQ:ROIC) announced today the following portfolio and operating statistics as of May 29, 2020:All 88 shopping centers are open and operating98% of total portfolio (86 shopping centers) are grocery and/or drug-store anchored76.5% of total tenants are open and operating (based on annualized base rent)71.0% of May 2020 billed monthly base rent has been paid to dateStuart A. Tanz, President and Chief Executive Officer of Retail Opportunity Investments Corp. stated, “Given that our tenant base is predominately comprised of essential businesses, providing daily-necessity goods and services to their communities, our portfolio continues to perform remarkably well during the COVID-19 pandemic, with our portfolio’s May performance being consistent with April. ...

SOUTH SAN FRANCISCO, Calif., June 01, 2020 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), today announced the pricing of an underwritten public offering of 11,702,128 shares of its common stock at a price to the public of $47.00 per share. The gross proceeds from this offering are expected to be approximately $550.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Allogene. The offering is expected to close on or about June 4, 2020, subject to customary closing conditions. In addition, Allogene has granted the underwriters a 30-day option to purchase up to 1,755,319 additional shares of its common stock at the public offering price, less the underwriting discounts and commissions.Goldman Sachs & Co. LLC, Jefferies LLC and Cowen and Company, LLC are acting...

VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) — North Arrow Minerals Inc. (TSXV-NAR) is pleased to announce it has entered into an option agreement with EHR Resources Ltd. (ASX–EHX) to fund further evaluation of the Q1-4 diamond deposit at the Naujaat Diamond Project, Nunavut. North Arrow presently maintains a 100% interest in the Project, including the Q1-4 diamond deposit, located only 9km from the coastal community of Naujaat.Under terms of the option agreement, EHR can earn a 40% interest in the Naujaat Project by investing $5.6M to collect a 1,500 to 2,000 tonne preliminary bulk sample during the 2021 summer field season. As part of the agreement, EHR has posted a $300,000 non-refundable advance to be used by North Arrow, as operator, to preposition fuel and other supplies by sealift in 2020. In order to proceed...

VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) —Loan AgreementPremier Diversified Holdings Inc. (“Premier” or the “Company“) (TSXV: PDH) announces that it has entered into a loan agreement with MPIC Fund I, LP (“MPIC“) for a secured loan in the aggregate principal amount of up to USD$150,000 (the “Loan“). The Loan matures on April 28, 2021 and bears interest at a rate of 6% per annum. Subject to certain exclusions, the Loan is secured with all of the present and after-acquired property of the Company and ranks equally in priority with all of the loans previously made to the Company by MPIC in 2019 and 2020.The Company is not issuing any securities, or paying any bonus, commission or finder’s fees on the Loan.  The Loan is repayable at any time without penalty.  The...

INDIANAPOLIS, June 01, 2020 (GLOBE NEWSWIRE) — Duke Realty Corporation (NYSE: DRE and the “company”), a leading logistics property real estate investment trust (REIT), announced today the results of rent collection and leasing activity for the months of April and May.  As of May 31st, the company noted the following metrics:Collected 98.3 percent of originally billed April rents with combined collections and deferrals totaling 99.8 percent;Collected 95.4 percent of originally billed May rents with combined collections and deferrals totaling 99.1 percent;Collecting May rents at a faster pace than April rents were collected;Cash collections do not include any security deposit or letters of credit applications;Collected 100 percent of rent in California and New Jersey, two states that have various eviction moratoriums, during the months...

VANCOUVER, British Columbia, June 01, 2020 (GLOBE NEWSWIRE) — VR Resources Ltd. (TSX.V: VRR; FSE: 5VR; OTCBB: VRRCF), the (Company), or (VR), announces that it has increased its previously announced (see NR20-04 dated May 25, 2020) non-brokered private placement offering (the “Offering”) to up to $2.2 million.  The Offering will now consist of up to 8,725,486 units (the “Units”) at a price of $0.22 per Unit. Each Unit will consist of one common share (“Common Share”) of the Company and one-half of a common share purchase warrant (“Warrant”), with each whole Warrant entitling the holder to acquire one additional Common Share at an exercise price of $0.35 per Common Share for a period of 18 months from the closing date (“Closing Date”) of the Financing, and up to 1,291,667 flow-through common shares (“FT Shares”) at a price of $0.24...